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ABSTRACT
Objective: Analyze the cases of posterior reversible encephalopathy syndrome (PRES) admitted in a Neurology Department during an
8-year period.Method: Retrospective observational study in a central hospital in the north of Portugal. Results:14 patients were identified,
mean age 52.3 years. Precipitating factors included: eclampsia, isolated arterial hypertension, spinal trauma and autonomic dysreflexia,
Guillain-Barré syndrome, sepsis, sarcoidosis and pulmonary cryptococcosis and drugs. Most patients presented posterior-predominant
vasogenic edema lesions, however 64.2% presented frontal lesions and in 42.8% cerebellum was involved. Four patients also had acute
ischemic lesions and 1 had hemorrhagic lesions. During follow-up 10 patients recovered fully, 2 recovered partially,1 suffered a recurrence
and 2 died in hospital. Conclusion: PRES has many etiological factors. The terms posterior and reversible should be revised because PRES
frequently involves other brain regions and it is not always reversible. PRES patients may develop life-threatening complications and
mortality is not negligible.
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RESUMO
Objetivo: Análise dos casos de síndrome de encefalopatia posterior reversível (PRES) internados em um Serviço de Neurologia durante oito
anos. Método: Estudo restrospectivo observacional num hospital central do norte de Portugal. Resultados: Identificaram-se 14 casos,
idade média de 52,3 anos. Os factores precipitantes foram: eclâmpsia, hipertensão arterial isolada, traumatismos vertebro-medulares
com disfunção autonómica, síndrome de Guillain-Barré, sépsis, sarcoidose e criptococose pulmonar e fármacos. A maioria dos doentes
apresentou lesões edematosas de predomínio posterior, contudo 64,2% apresentaram lesões frontais e 42,8% apresentaram também
lesões cerebelosas. Quatro doentes tinham lesões isquémicas agudas e um apresentou lesões hemorrágicas. Durante o seguimento, 10
doentes recuperaram totalmente, 2 recuperaram com sequelas, 1 teve recidiva e 2 faleceram durante o internamento. Conclusão: A PRES
apresenta muitos factores precipitantes. As designações posterior e reversível deverão ser reequacionadas dado que a PRES afecta outras
zonas do cérebro e nem sempre é reversível, apresentado complicações e mortalidade não negligenciáveis.
Palavras-chave: síndrome de encefalopatia posterior reversível, edema vasogénico, hipertensão arterial.
Posterior reversible encephalopathy syndrome (PRES)
was initially described in patients presenting with sudden
onset headache, mental status changes, visual disturbances
and seizures associated with a predominantly posterior leu-
koencephalopathy1. Reversibility and posterior region pre-
dominance of lesions were main features in its original
description. The first reported cases were mainly related
to arterial hypertension (hypertensive encephalopathy),
hypertension in pregnancy (namely eclampsia) and
immunosuppressive therapy1,2. PRES is an increasingly
recognized syndrome and since its original description other
series have been published3, presenting cases with atypical
features and revealing new causes and associated conditions
(inflammatory or auto-immune diseases, systemic inflam-
matory response syndrome, electrolyte imbalances, spinal
injuries, Guillain-Barré syndrome (GBS), vasoactive drugs,
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chemotherapy agents and monoclonal antibodies)3,4. PRES
pathophysiology remains unclear, but cerebral autoregulation
impairment as well as endothelial dysfunction are proposed
to be the most important underlying mechanisms5.
Neuroimaging has a major role in the diagnosis of this entity6,7.
MRI is the best exam to diagnose PRES although CT is also
useful. Lesions are usually located in the parieto-occipital
region sparing calcarine and paramedian regions of the occi-
pital lobe. Nevertheless, there may be lesions in the frontal
lobe, cerebellum and diencephalon. Based on their location,
four topographic patterns were described: mainly parietal-
occipital pattern, superior frontal sulcus pattern, holo-
hemispheric watershed pattern, and partial or asymmetric
expression of the primary patterns8. PRES usually has a benign
prognosis and is reversible after correction or removal of the
precipitating factor and blood pressure control1,2.
The aim of this paper is to review our series of patients
with PRES, comparing clinical, imagiological and etiological
aspects with previous literature.
METHOD
Retrospective and descriptive study developed in a cent-
ral hospital in the north of Portugal. Patient selection and
data collection was performed using the electronic patient’s
database. Patients admitted with the diagnosis of PRES
between January 2005 and September 2013 were included
in this study. Two cases included were previously reported9.
The criteria of inclusion were: (1) acute or subacute neuro-
logic syndrome characterized by seizures, encephalopathy,
headache, visual disturbance or focal deficit; (2) neuroima-
ging findings consistent with the diagnosis of PRES, namely
otherwise unexplained focal or diffuse vasogenic edema
lesions. Patients with edematous lesions secondary to
ischemic, hemorrhagic, infectious, inflammatory or space-
occupying lesions were excluded. Hypertension was defined
as a systolic blood pressure of 140 mmHg or greater and/or a
diastolic blood pressure of 90 mmHg or greater.
Clinical and radiological files were systematically ana-
lyzed and the following variables were recorded: gender,
age, signs and symptoms, blood pressure at admission,
lesions topography in brain imaging, presence of ischemic
and hemorrhagic lesions, etiological factors, association with
previous cardiovascular risk factors, complications, recur-
rences and mortality. This study was conducted according
to local Ethics Committee requirements.
RESULTS
Fourteen patients were included (57% males), mean age
was 52.3 years (20-89). Half of the patients presented with
seizures (7/14), three patients with headaches, three with
visual disturbances (visual hallucinations, campimetric defi-
cits and cortical blindness with Anton syndrome) and one
patient presented with focal motor deficit. Table 1 displays
clinical manifestations in the course of the disease of all
patients. Most patients (13/14) had high blood pressure on
admission: mean systolic pressure (sBP) was 172.6 mmHg
(111-206), mean diastolic pressure (dBP) was 92.2 mmHg
(64-121) and mean mean blood pressure (mBP) was
109.1 mmHg (80-149). Four patients had previous history
of hypertension. The only patient presenting with normal
blood pressure had a spinal trauma with autonomic dysfunc-
tion. Regarding other cardiovascular risk factors, 5 patients
had dyslipidemia, 4 patients had diabetes and 2 patients
were smokers. Six patients presented more than one risk
factor simultaneously.
Thirteen patients performedMRI. In one patient, diagnosis
was supported exclusively by brain CT. Two patients had no
abnormalities in CT, but subsequent MRI revealed findings
suggestive of PRES. Table 2 shows brain lesions characteristics
found in these patients. The majority of patients presented
lesions in other locations besides the posterior parieto-
occipital region and in 3/14 patients this region was not pre-
dominantly affected. Almost one third of patients presented
ischemic or hemorrhagic lesions. Figure shows the main
radiological findings. Seven patients performed video electro-
encephalogram and among those 6 had slowing of back-
ground activity, localized or generalized slowing of activity,
suggesting encephalopathic cortical dysfunction.
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Acute ischemic lesions 4
Parenchymal hemorrhage 1
Angiography changes* 0
*Angiographic study was performed in 5 patients using MRI. N: Number of
cases.
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Among etiological factors, eclampsia was the most fre-
quent (4 patients), followed by isolated high blood pressure
(3 patients) and spinal trauma with autonomic dysfunction
(2 patients). Other factors identified were sepsis, sarcoidosis
and concomitant pulmonary cryptococcosis, GBS, octreotide
perfusion and chemotherapy (Table 3).
Duration of follow-up was variable (3 weeks-8 years).
Most patients presented a partial or complete recovery
(Table 4). Brain MRI was repeated in 8 patients and in seven
patients lesions disappeared. Two patients developed neuro-
logical sequelae (epilepsy, severe focal motor deficit). Two
patients died after onset. One patient developed rapidly pro-
gressive bilateral edema and acute ischemic lesions, with
mass effect, intracranial hypertension refractory to medical
therapy, and died 19 days after admission. The other patient
had been submitted to abdominal surgery for gastric cancer,
presented with PRES after octeotride perfusion and died of
sepsis related to esophago-jejunal anastomosis leak 3 weeks
later. One case of recurrence was observed two months after
the first event. This patient had a persistent autonomic dys-
function related to spinal trauma.
DISCUSSION
This study describes the clinical and radiological features
of 14 patients with PRES, affecting individuals of all ages. In
this series there was a male predominance, although in other
series there is a slight female predominance, even when
eclampsia associated cases are not taken into account10,11.
In most patients of our series, the identified causes were
those classically described, namely, eclampsia and high
blood pressure. Nevertheless, the cases associated with
autonomic dysfunction related to spinal trauma, sepsis, sar-
coidosis and pulmonary cryptococcosis, GBS and drugs
demonstrate the diversity of precipitating factors that cul-
minate in a common clinical-radiological syndrome3,12,13.
High blood pressure was present in the majority of patients,
supporting the hypothesis of cerebral autoregulation impair-
ment as the main pathogenic mechanism in PRES1,10. When
cerebral autoregulation capacity is overcome by systemic
blood pressure, cerebral hyperperfusion emerges, damaging
the blood brain barrier and originating liquid leakage to
the extracellular space and vasogenic edema, mainly in
arterial border territories1,10,14,15,16. The fact that only 4
patients had previous high blood pressure supports the idea
that sudden elevation of blood pressure prevents vascular
adaptation to take place. The mean mBP in our patients ser-
ies (109 mmHg) was inferior to the considered upper
limit value of cerebral autoregulation, situated around
150 mmHg17. However, Liman et al.11 demonstrated that
mBP was not correlated with edema severity, while sBP
had a positive correlation with edema severity supporting
Figure. PRES radiological characteristics. (A) CT, bilateral
posterior parietal and frontal cortico and subcortical hypo-
dense lesions; (B) MRI, FLAIR, bilateral temporo-occipital
hyperintense lesions; (C-D) MRI, FLAIR, bilateral frontal cortical
and subcortical lesions; (E) MRI, FLAIR, typical hyperintense
bilateral occipital associated with bilateral thalamic lesions;
(F-G) MRI, DWI, multiple bilateral cerebellar lesions presenting
restriction to diffusion (recent ischemic lesions); and (H-I) RMI,
FLAIR and T2 echo-gradient, revealing typical predominately
posterior PRES lesions associated with a right temporo-
occipital hemorrhage.
Table 3. Identified precipitating factors.
N
Eclampsia 4
High blood pressure 3
Autonomic dysfunction related to spinal trauma 2
Sepsis 1
Pulmonary sarcoidosis and cryptococcosis 1
Guillain-Barré syndrome 1
Octreotide perfusion 1
Chemotherapy (Cisplatin, Gemcitabine, Bevacizumab)* 1
*Hypomagnesemia was also present (cisplatin side effect but also
potentially pathogenic). N: Number of cases.






N: Number of cases.
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the hypothesis of the acute lesion of the blood-brain barrier.
In this series there was only one patient with normal blood
pressure, contrasting with other reports where 20%-30% of
patients with PRES presented without high blood pressure9.
The 2 cases related to autonomic dysfunction associated
with spinal trauma support the role of the sympathetic nerv-
ous system dysfunction in PRES at least in some patients9.
In addition to blood pressure, other mechanisms that cause
endothelial dysfunction, blood brain barrier impairment and
cerebral edema could also be involved, and the cases asso-
ciated with sepsis, sarcoidosis and drugs may be illustrative
of this hypothesis. In this series one patient treated with
bevacizumab developed PRES. In fact, there is a growing
number of PRES cases occurring in patients treated with
anti-vascular endothelial growth factor agent (anti-VEGF) as
bevacizumab. This drug interferes with vascular permeability
and with endothelium intracellular signaling pathways sup-
porting the endothelial dysfunction role in this disease18.
Concerning topography of lesions, most patients pre-
sented predominantly posterior parietal-occipital lesions
which may be explained by the lower density of sympathetic
fibers in the vertebrobasilar territory, making it more suscept-
ible to systemic blood pressure oscillations1,19. Nevertheless,
64.2% presented frontal lobe lesions and 42.8% also presented
cerebellar lesions, in accordance to other series3,10,11,13.
Thus, posterior in PRES designation may be inadequate.
Furthermore, this syndrome was initially described as a white
matter disease1, but in 92.8% of our patients, cortical involve-
ment was demonstrated.
It has been suggested that in PRES, arteriolar vasocon-
striction occurs in response to cerebral hyperperfusion,
thus leading to hypoperfusion, ischemia and subsequent
edema10,15,16. Although angiographic studies demonstrate
focal or diffuse vasoconstriction, ischemic complications
are not frequent20. Acute ischemic complications occurred
in 4/14 (28.6%) of our patients, in accordance to what is
described in the literature11,16. There was only one case of
cerebral hemorrhage (7.1%) in this series. However in the
literature, hemorrhagic complications occur in 15 to 32%
of cases, mostly in the form of petechial bleeding11,16.
Ten of 14 patients experienced a complete clinical
recovery, supporting the reversibility of this syndrome.
Follow-up MRI showed partial or complete improvement
of brain lesions in 7/8 patients. Liman et al.11 reported a
partial or complete recovery of lesions in 82% of patients
during follow-up. Recurrent PRES episodes are rare11,13,
and occurred in 1/14 patient in this series. The adequate
control of blood pressure and the elimination of all other
precipitating factors should be achieved during acute man-
agement and follow-up21. Among patients that recovered
partially, one developed motor sequelae and the other
developed epilepsy. Furthermore, 2 patients (14.3%) died,
and death was attributed directly to PRES in one of them.
Rarely this entity may complicate with progressive cerebral
edema, intracranial hypertension and death1,10,11. Morbidity
and mortality in this series (28.6%) prove that PRES is not
always reversible and benign.
This study had several limitations associated with its
retrospective design and related to the population size.
Imagiological evaluation was not uniform in all patients
and angiographic study was absent in 9/14 patients.
Follow-up was not homogeneous, mainly in what concerns
to radiological reevaluation. In depth analysis of clinical
and analytical variables with prognostic significance was
not performed due to the lack of statistical power.
In conclusion, PRES should be rapidly recognized in
emergency settings. It is a clinical-radiological entity whose
pathophysiology is not fully understood and with a diversity
of precipitating factors. The denomination posterior and
reversible has its origin in the first description by Hinchey1
but the growing number of reported cases, including the pre-
sent series, show the frequent involvement of other brain
regions and less favorable outcomes with significant morbid-
ity and mortality. While pathophysiological mechanisms are
not fully understood the current designation remains useful,
although it does not encompass its clinical and radiological
diversity. PRES, reversible vasoconstriction syndrome and
cerebral hyperperfusion syndrome may partially share com-
mon pathological mechanisms and they may all belong to a
larger spectrum of acquired vasculopathies.
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